Promising breakthrough for fatty liver patients: Resistant starch cuts liver fat

Written By :  Isra Zaman
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-09-12 04:15 GMT   |   Update On 2024-01-29 11:18 GMT
Advertisement

An estimated 30% of the world's population currently has non-alcoholic fatty liver disease (NAFLD), which has reached epidemic proportions globally. It is a multisystem disease that may not only develop into severe chronic hepatic diseases but also contribute to extrahepatic diseases such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, causing a tremendous clinical and economic burden.

Advertisement

To investigate the effects of resistant starch (RS) as a microbiota-directed dietary supplement for NAFLD treatment, the researchers coupled a 4-month randomized placebo-controlled clinical trial in individuals with NAFLD with metagenomics and metabolomics analysis.

A total of 200 participants with NAFLD were recruited and randomized with a 1:1 allocation to the 4-month administration of RS type 2 from high-amylose maize or control starch with equal energy supply.

Relative to the control, the RS intervention resulted in a 9.08% absolute reduction of intrahepatic triglyceride content (IHTC), which was 5.89% after adjusting for weight loss. Serum branched-chain amino acids (BCAAs) and gut microbial species, in particular Bacteroides stercoris, significantly correlated with IHTC and liver enzymes and were reduced by RS.

Multi-omics integrative analyses revealed the interplay among gut microbiota changes, BCAA availability, and hepatic steatosis, with causality supported by fecal microbiota transplantation and monocolonization in mice. Thus, RS dietary supplementation might be a strategy for managing NAFLD by altering gut microbiota composition and functionality.

Reference: Yueqiong Ni et al, Cell Metabolism 35, 1530–1547, September 5, 2023, DOI: https://doi.org/10.1016/j.cmet.2023.08.002

Full View
Tags:    
Article Source : Cell Metabolism

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News